- Tytuł:
- Dupilumab efficacy and safety up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from parts B and C of the randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study
- Autorzy:
- Źródło:
- In Revue Française d'Allergologie April 2023 63(3)
Czasopismo naukowe